Omeros | OMER - 流动负债



金融业
股票价格
USD
资产
USD 200.57M
现金及等价物
USD 1.9M
销售成本
USD 33.16M
流动资产
USD 69.65M
流动负债
USD 85.5M
债务
USD 442.16M
股息收益率
0
EBIT
USD -48.15M
EBITDA
USD -47.96M
员工
196
EPS每股收益
USD -1.12
股本和储备
USD -228.69M
销售毛利
USD -33.16M
债务利息支出
USD 4.05M
贷款资金
USD 403.72M
市值
USD 928.5M
净收入
USD -32.23M
营业费用
USD 59.16M
营业利润
USD -35.41M
普通股股本
USD 611K
税前利润
USD -65.12M
销售收入
USD 0
销售和管理费用
USD 11.32M
股票
USD 712K
贸易债权人
USD 8.84M
应收帐款人
USD 8.08M


流动负债 更改 日
Adma Biologics USD 69.54M 13.05M 2025-12
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Cytokinetics USD 199.18M 3.27M 2026-03
Gilead Sciences USD 11.81B 485M 2025-12
Heron Therapeutics USD 96.1M 6.39M 2025-12
Immunic USD 30.62M 539K 2025-12
Insmed USD 468.87M 51.66M 2025-12
Knight Therapeutics CAD 165.26M 12.58M 2025-12
MacroGenics USD 43.11M 1.36M 2025-12
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 108.79M 11.8M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Rockwell Medical USD 10.95M 259K 2025-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
United Therapeutics USD 599.1M 38.5M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03
Xoma USD 28.3M 6.81M 2025-09